Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Naohiko, Inase"'
Autor:
Hiroyuki Sakashita, Ken Uchibori, Yasuto Jin, Toshiharu Tsutsui, Takayuki Honda, Rie Sakakibara, Takahiro Mitsumura, Yoshihisa Nukui, Tsuyoshi Shirai, Masahiro Masuo, Kozo Suhara, Haruhiko Furusawa, Takaaki Yamashita, Takehiko Ohba, Kazuhito Saito, Jun Takagiwa, Yoshihiro Miyashita, Naohiko Inase, Yasunari Miyazaki
Publikováno v:
Thoracic Cancer, Vol 13, Iss 9, Pp 1267-1275 (2022)
Abstract Background A standard treatment regimen for advanced non‐small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) has not been established since most clinical trials exclude such patients because of the high risk of acu
Externí odkaz:
https://doaj.org/article/fe5bbcf9dbb64b87b0926aa52b897ff9
Autor:
Yoshinori Hasegawa, Yasuhiko Nishioka, Shinyu Izumi, Sakae Homma, Yoshikazu Inoue, Takumi Kishimoto, Yutaro Nakamura, Takafumi Suda, Kazuya Ichikado, Takeshi Johkoh, Naoki Hamada, Koichi Hagiwara, Akira Hebisawa, Naohiko Inase, Ryoko Egashira, Kinya Abe, Masaki Okamoto, Motoyasu Kato, Yasuhiro Terasaki, Yuko Toyoda, Tomohisa Baba, Yuji Fujikura, Etsuo Fujita, Tomohiro Handa, Koko Hidaka, Takeshi Hisada, Shu Hisata, Chisato Honjo, Keisuke Miki, Masamichi Mineshita, Susumu Sakamoto, Masaaki Sano, Yoshikazu Tsukada, Mari Yamasue, Yoshimi Bando
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Background Diffuse pulmonary ossification is a specific lung condition that is accompanied by underlying diseases. However, idiopathic dendriform pulmonary ossification (IDPO) is extremely rare, and the clinical features remain unclear. In this study
Externí odkaz:
https://doaj.org/article/8c58aad29edf4c72b4c8c6193b072fe5
Autor:
Yoshihisa Nukui, Yasunari Miyazaki, Masahiro Masuo, Tsukasa Okamoto, Haruhiko Furusawa, Tomoya Tateishi, Mitsuhiro Kishino, Ukihide Tateishi, Junya Ono, Shoichiro Ohta, Kenji Izuhara, Naohiko Inase
Publikováno v:
Allergology International, Vol 68, Iss 3, Pp 363-369 (2019)
Background: Periostin is an established biomarker of Th2 immune response and fibrogenesis. Recent research has indicated that periostin plays an important role in the pathogenesis of idiopathic interstitial pneumonias. To clarify the relationship bet
Externí odkaz:
https://doaj.org/article/e85cc5f3e2794b7dba7426f527fe4983
Autor:
Yuji Minegishi, Akihiko Gemma, Sakae Homma, Kazuma Kishi, Arata Azuma, Takashi Ogura, Naoki Hamada, Hiroyuki Taniguchi, Noboru Hattori, Yasuhiko Nishioka, Kiminobu Tanizawa, Takeshi Johkoh, Takuma Yokoyama, Kazutaka Mori, Yoshio Taguchi, Masahito Ebina, Naohiko Inase, Koichi Hagiwara, Hiroshi Ohnishi, Hiroshi Mukae, Yoshikazu Inoue, Kazuyoshi Kuwano, Hirofumi Chiba, Ken Ohta, Yoshinori Tanino, Fumikazu Sakai, Yukihiko Sugiyama
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
Background Chemotherapy-induced acute exacerbation (AEx) of idiopathic interstitial pneumonias (IIPs) seriously compromises the success of treatment of Japanese lung cancer patients. Here, we conducted a nationwide surveillance to clarify the risk of
Externí odkaz:
https://doaj.org/article/cb0c5fba38b64afd8768933649abc643
Autor:
Manabu Sema, Yasunari Miyazaki, Toshiharu Tsutsui, Makoto Tomita, Yoshinobu Eishi, Naohiko Inase
Publikováno v:
Immunity, Inflammation and Disease, Vol 6, Iss 1, Pp 154-162 (2018)
Abstract Background In chronic hypersensitivity pneumonitis (chronic HP), antigen avoidance is critical for disease management; however, complete avoidance is difficult because of unrecognized exposure to antigens. Recently, we revealed that the amou
Externí odkaz:
https://doaj.org/article/180d6831433b4d9d8c3df8a341976c77
Autor:
Tsuyoshi Shirai, Haruhiko Furusawa, Asuka Furukawa, Yuki Ishige, Keisuke Uchida, Yasunari Miyazaki, Yoshinobu Eishi, Naohiko Inase
Publikováno v:
Respiratory Research, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background Avian antigen is a common cause of hypersensitivity pneumonitis (HP). Inhalation challenge with pigeon serum and pigeon dropping extract (PDE) elicits a hypersensitivity reaction in patients with bird-related hypersensitivity pneu
Externí odkaz:
https://doaj.org/article/2e8784fe8cc94998bbf23dd8d32c4bea
Autor:
Ken Uchibori, Naohiko Inase, Mitsugu Araki, Mayumi Kamada, Shigeo Sato, Yasushi Okuno, Naoya Fujita, Ryohei Katayama
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-16 (2017)
Resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer is mediated by the C797S/T790M/activating mutation. Here, the authors identify brigatinib as a potential drug that in combination with anti-EGFR can overcome resistance in mu
Externí odkaz:
https://doaj.org/article/7e03180accc34d52b7997deb52cfee5f
Autor:
Yoshifumi Kimizuka, Yoshihiko Hoshino, Tomoyasu Nishimura, Takahiro Asami, Yumi Sakakibara, Kozo Morimoto, Shinji Maeda, Noboru Nakata, Takayuki Abe, Shunsuke Uno, Ho Namkoong, Hiroshi Fujiwara, Yohei Funatsu, Kazuma Yagi, Toshihide Fujie, Makoto Ishii, Naohiko Inase, Satoshi Iwata, Atsuyuki Kurashima, Tomoko Betsuyaku, Naoki Hasegawa, Non-Tuberculous Mycobacteriosis-Japan Research Consortium (NTM-JRC)
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0216034 (2019)
BackgroundThere is no proven management for mild cases of Mycobacterium avium complex (MAC) pulmonary disease, who do not immediately receive treatment and are managed with observation alone, because its long term-natural course, factors predictive o
Externí odkaz:
https://doaj.org/article/3cf489711f2142fab2a642e1fcba03d9
Publikováno v:
European Respiratory Review, Vol 27, Iss 150 (2018)
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has increased over recent years, but information on the prevalence and incidence of ILDs of different aetiologies remains limited. Despite global distribution, the
Externí odkaz:
https://doaj.org/article/4914808166a245638ac40bd84aef8e9f
Autor:
Hiroyuki Sakashita, Ken Uchibori, Yasuto Jin, Toshiharu Tsutsui, Takayuki Honda, Rie Sakakibara, Takahiro Mitsumura, Yoshihisa Nukui, Tsuyoshi Shirai, Masahiro Masuo, Kozo Suhara, Haruhiko Furusawa, Takaaki Yamashita, Takehiko Ohba, Kazuhito Saito, Jun Takagiwa, Yoshihiro Miyashita, Naohiko Inase, Yasunari Miyazaki
Publikováno v:
Thoracic Cancer. 13:1267-1275
A standard treatment regimen for advanced non-small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) has not been established since most clinical trials exclude such patients because of the high risk of acute exacerbation of ILD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6331304c22f86befa1cac6e73002176b
https://doi.org/10.1111/1759-7714.14376
https://doi.org/10.1111/1759-7714.14376